Clinical usefulness of SonoVue contrast echocardiography: The Thoraxcentre experience

Netherlands Heart Journal

Volumn 15, Issue 2, 2007, Pages 55-60

  Galema, T W ^a   Geleijnse, M L ^a   Vletter, W B ^a   De Laat, L ^a   Michels, M ^a   Ten Cate, F J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Clinical practice; Echocardiography; SonoVue

Indexed keywords

CLEMASTINE; DOBUTAMINE; HYDROCORTISONE; SONOVUE;

ANAPHYLACTIC SHOCK; CARDIOMYOPATHY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEFIBRILLATOR; DIAGNOSTIC IMAGING; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ERYTHEMA; FLUSHING; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HUMAN; HYPOTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SIDE EFFECT; SINUS TACHYCARDIA; STRESS ECHOCARDIOGRAPHY; THROMBUS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 34547875729     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03085955     Document Type: Review

References (24)

1. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol 1998;32:1426-32.
2. Kasprzak JD, Paelinck B, Ten Cate FJ, et al. Comparison of native and contrast-enhanced harmonic echocardiography for visualization of left ventricular endocardial border. Am J Cardiol 1999;83:211-7.
3. Sieswerda GT, Kamp O, Visser CA. The use of contrast agents in echocardiography. Part I: History, Principles and Developments in Agents and Ultrasound Technology. Neth Heart J 1998;5:583-8.
4. Sieswerda GT, Kamp O, Visser CA. The use of contrast agents in echocardiography. Part II: clinical indications and experimental applications. Neth Heart J 1998;5:648-57.
5. Schneider M. SonoVue, a new ultrasound contrast agent. Eur Radiol 1999;9(Suppl 3):S347-8.
6. Mor-Avi V, Caiani EG, Collins KA, Korcarz CE, Bednarz JE, Lang RM. Combined assessment of myocardial perfusion and regional left ventricular function by analysis of contrast-enhanced power modulation images. Circulation 2001;104:352-7.
7. Biagini E, Galema TW, Schinkel AF, Vletter WB, Roelandt JR, Ten Cate FJ. Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2004;43:1489-93.
8. Dolan MS, Riad K, El-Shafei A, et al. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 2001;142:908-15.
9. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2004;44:1030-5.
10. Thomson HL, Basmadjian AJ, Rainbird AJ, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J Am Coll Cardiol 2001;38:867-75.
11. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
12. Rocchi G, Kasprzak JD, Galema TW, de Jong N, Ten Cate FJ. Usefulness of power Doppler contrast echocardiography to identify reperfusion after acute myocardial infarction. Am J Cardiol 2001;87:278-82.
13. Sieswerda GT, Klein LJ, Kamp O, et al. Quantitative evaluation of myocardial perfusion in patients with revascularized myocardial infarction: comparison between intravenous myocardial contrast echocardiography and 99mTc-sestamibi single photon emission computed tomography. Eur J Echocardiogr 2004;5:41-50.
14. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998;98:2415-21.
15. Faber L, Seggewiss H, Welge D, et al. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. Eur J Echocardiogr 2004;5:347-55.
16. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001;86:666-71.
17. de Laat LE, Galema TW, Krenning BJ, Roelandt JR. Diagnosis of non-compaction cardiomyopathy with contrast echocardiography. Int J Cardiol 2004;94:127-8.
18. van den Bosch AE, Meijboom FJ, McGhie JS, Roos-Hesselink JW, Ten Cate FJ, Roelandt JR. Enhanced visualisation of the right ventricle by contrast echocardiography in congenital heart disease. Eur J Echocardiogr 2004;5:104-10.
19. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-8.
20. Mathias W, Jr. Arruda AL, Andrade JL, Filho OC, Porter TR. Endocardial border delineation during dobutamine infusion using contrast echocardiography. Echocardiography 2002;19:109-14.
21. Ten Cate FJ. Usefulness of ultrasound contrast for image enhancement during stress echocardiography. Echocardiography 2002;19(7 Pt 2):621-5.
22. de Groot MC, van Zwieten-Boot BJ, van Grootheest AC. [Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent]. Ned Tijdschr Geneeskd 2004;148:1887-8.
23. Fisher AA. Immediate and delayed allergic contact reactions to polyethylene glycol. Contact Dermatitis 1978;4:135-8.
24. Dewachter P, Mouton-Faivre C. Anaphylaxis to macrogol 4000 after a parenteral corticoid injection. Allergy 2005;60:705-6.